Reports of the possible role of other genes such as KIF23, CENPE, MUTYH, POLE, and POLD1 in genetic predisposition for CRC and presence of a mutation in specific genes in populations affected by CRC are all suggestive of unidentified features of personalized medicine for colorectal cancer. Here, MUTYH is linked to colorectal carcinoma.